Get the Stockscreener App
167.33
1.57%
2.59
After Hours:
167.25
-0.08
-0.05%
Overview
News
Price History
Option Chain
Financials
Why JNJ Down?
Discussions
Forecast
Stock Split
Dividend History
Johnson Johnson stock is traded at $167.33, with a volume of 8.91M.
It is up +1.57% in the last 24 hours and up +7.32% over the past month.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
See More
Previous Close:
$164.74
Open:
$165.475
24h Volume:
8.91M
Relative Volume:
1.10
Market Cap:
$402.61B
Revenue:
$90.63B
Net Income/Loss:
$22.66B
P/E Ratio:
17.90
EPS:
9.35
Net Cash Flow:
$16.40B
1W Performance:
-0.58%
1M Performance:
+7.32%
6M Performance:
+9.98%
1Y Performance:
+4.09%
1-Day Range:
$164.79
$167.62
1-Week Range:
$164.23
$168.78
52-Week Range:
$140.68
$169.99
Johnson Johnson Stock (JNJ) Company Profile
Name
Johnson Johnson
Sector
Industry
Phone
732-524-2455
Address
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ
Compare JNJ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JNJ
Johnson Johnson
|
167.33 | 396.75B | 90.63B | 22.66B | 16.40B | 9.35 |
|
LLY
Lilly Eli Co
|
762.33 | 664.39B | 49.00B | 11.11B | -1.27B | 12.29 |
|
ABBV
Abbvie Inc
|
195.22 | 333.89B | 58.33B | 3.76B | 15.39B | 2.10 |
|
NVS
Novartis Ag Adr
|
115.30 | 220.18B | 55.19B | 13.65B | 16.81B | 6.86 |
|
MRK
Merck Co Inc
|
79.29 | 196.16B | 63.62B | 16.41B | 17.04B | 6.49 |
Johnson Johnson Stock (JNJ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-25 | Upgrade | Erste Group | Hold → Buy |
| May-13-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Jul-23-24 | Downgrade | Daiwa Securities | Outperform → Neutral |
| May-30-24 | Resumed | Goldman | Neutral |
| Apr-18-24 | Upgrade | HSBC Securities | Hold → Buy |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-01-23 | Upgrade | UBS | Neutral → Buy |
| Oct-05-23 | Initiated | RBC Capital Mkts | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Resumed | Citigroup | Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-01-23 | Initiated | Guggenheim | Neutral |
| Nov-18-22 | Initiated | Credit Suisse | Neutral |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-14-22 | Reiterated | BofA Securities | Neutral |
| Jun-22-22 | Initiated | Daiwa Securities | Outperform |
| May-23-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-16-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-17-21 | Initiated | Goldman | Neutral |
| Dec-15-21 | Reiterated | Citigroup | Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-28-21 | Resumed | Morgan Stanley | Overweight |
| Apr-28-20 | Downgrade | UBS | Buy → Neutral |
| Apr-22-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-19-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-17-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-20-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-16-19 | Upgrade | Atlantic Equities | Underweight → Neutral |
| Oct-11-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jul-12-19 | Resumed | Credit Suisse | Outperform |
| May-28-19 | Initiated | Goldman | Buy |
| Jan-23-19 | Reiterated | Barclays | Equal Weight |
| Jul-12-18 | Upgrade | Goldman | Sell → Neutral |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-23-18 | Reiterated | Citigroup | Neutral |
| Apr-18-18 | Reiterated | Stifel | Hold |
| Jan-24-18 | Reiterated | Stifel | Hold |
| Jan-12-18 | Reiterated | Wells Fargo | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-18-17 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-18-17 | Reiterated | Stifel | Hold |
View All
Johnson Johnson Stock (JNJ) Latest News
Land of milk and money: Why this region’s bucking the slump - Stuff
'I feel like I can do everything in this offense': Rookie WR Luther Burden starting to emerge - ESPN
Chicago Democrats issue warnings about their mayor amid Zohran Mamdani's rise - NBC News
The 3 Things That Matter for Johnson & Johnson Now - The Motley Fool
Marva Brown Johnson Strikes Boldly on Her First Day as Florida A&M University’s 13th PresidentFlorida A&M University - Florida A&M University - FAMU
Motor Finance Cases | Supreme Court Judgment in Johnson, Wrench and Hopcraft - Travers Smith
Birmingham siblings, 11 and 13, who drowned in Spain named - BBC
Johnson Named to 2025 Jet Award Preseason Watch List - pittsburghpanthers.com
Medicare and Medicaid Turn Sixty - The Century Foundation
Fact check: Photograph shows Boris Johnson and ex-wife at university - The Independent
Johnson & Johnson Stock: Analyst Estimates & Ratings - Yahoo Finance
Fall Camp Day 2: Dalton Johnson and Tre Smith - Sports Illustrated
Superintendent Interviews: Bristol, Tennessee and Johnson County - WJHL
Speaker Johnson and Staff in Rice Country - USA Rice Federation
Darnell Johnson Signs For Oxford City - OXFORD CITY FC
Competitive Buffs Fall To Boomers - University of Colorado Athletics
Luther Burden III on Ben Johnson's standard, learning the offense | Press Conference - Chicago Bears
Johnson and Johnson: Ageless defensive tackle celebrates two-sack gem - Saskatchewan Roughriders
Johnson: I have prostate cancer — and the faith to beat it - AL.com
C.J. Gardner-Johnson on facing Texans' revamped WR corps in camp: 'It's like the Daytona 500' - NFL.com
Johnson & Johnson to acquire Erickson-Larsen assets in Midwest expansion - Insurance Business America
Johnson & Johnson to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - BioSpace
Will Johnson, Walter Nolen III Spend Off Day Hosting Community Event - Arizona Cardinals
Calling the Shots: Tracking RFK Jr. on Vaccines - U.S. News & World Report
What Tampa Bay Star Mike Evans Said About Rookie Receivers Tez Johnson, Emeka Egbuka - Sports Illustrated
Mass. family awarded $42.6M in mesothelioma lawsuit against J&J - WCVB
J&J, Legend crunch the multiple myeloma numbers in first Carvykti TV ad - Fierce Pharma
Moolenaar, Johnson Safeguard U.S. Infrastructure from Chinese Spy Technology - Select Committee on the CCP | (.gov)
Lions Graham Glasgow Says Ben Johnson Was Little More 'Uppity' - Sports Illustrated
J&J tests direct CAR-T marketing with first Carvykti ad - BioPharma Dive
Extreme environmental chamber aids research on heat and cold ‘relevant to every human’ - News at IU
Capitol agenda: Insider trading is Mike Johnson’s next Epstein - Politico
Free agency NBA Power Rankings: Where the Rockets, Raptors and others land this offseason - ESPN
The Zacks Analyst Blog Highlights Broadcom, Berkshire Hathaway, Johnson & Johnson, Oil-Dri Corp. of America and Park Aerospace - Yahoo Finance
Caleb Williams Work Ethic Addressed By Chicago Bears' Ben Johnson - Sports Illustrated
Johnson & Johnson MedTech introduces AI solution for bunion procedures - Yahoo Finance
Broken Hill man jailed for 'very distressing' animal abuse in social media videos - Australian Broadcasting Corporation
Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case - Yahoo Finance
Johnson & Johnson ordered to pay $42-million after U.S. jury finds talc caused man’s cancer - The Globe and Mail
Johnson & Johnson ordered to pay $42M after jury finds talc caused man’s cancer - Reuters
NewsHelping Hands and Healing Paws in Kosovo - DVIDS
Top Analyst Reports for Broadcom, Berkshire Hathaway & Johnson & Johnson - Yahoo Finance
Hematologist Dissatisfaction with Current Warm Autoimmune Hemolytic Anemia (w-AIHA) Treatment Spurs Interest in Late-Stage Pipeline, According to Spherix Global Insights - GlobeNewswire Inc.
Robert Wood Johnson University Hospital, Cooperman Barnabas Medical Center Named Best Regional Hospital - RWJBarnabas Health
Bears HC Ben Johnson Speaks Out Amid Concerns With Offense - Newsweek
Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions - Yahoo Finance
MOD confirms the death of Private Harry Johnson - The British Army
Johnson & Johnson (JNJ) Upgraded to Buy as Growth and Margins Impress Analysts - Yahoo Finance
Aaron Taylor-Johnson - Britannica
FDA and Kratom - fda.gov
Courts Question Legal Tactics as J&J and Avon Confront Growing Talc Liability - Mesothelioma Center
Johnson Johnson Stock (JNJ) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):